International Society for Quality of Life Research
International Society for Quality of Life Research

Industry Special Interest Group (I-SIG)

[Formerly the Industry Advisory Committee (IAC)]

Who is the I-SIG?

The Industry Special Interest Group (I-SIG) members are a diverse group of researchers from the pharmaceutical and device industry, academia and consulting, who share a common interest in the application of patient-centered outcomes, including health-related quality of life (HRQOL), in research important to industry.

We are interested in innovative methods and research in patient-centered outcomes measurement for use in research important to industry.

What are our aims?

The purpose of the I-SIG is to synthesize, share, promote and educate on industry-related patient-centered outcomes research by bringing individuals together who are interested in topics of joint interest to industry and ISOQOL.

Our specific goals are to:

  • Learn, develop and promote best practice in the field of patient-centered outcomes research and implementation in industry-related research
  • Provide support to I-SIG members and stimulate research in this field
  • Encourage I-SIG members to meet and share relevant research and experiences through ISOQOL and at other professional meetings
  • Increase awareness among the general ISOQOL members of issues important to industry

Our research includes, among others topics:

  • Methods for selecting, developing or adapting patient-centered outcomes instruments for use in industry-related research
  • Testing the feasibility and usability of patient-centered outcomes instruments
  • Implementation of patient-centered outcomes instruments in industry-related research
  • Design of studies involving patient-centered outcomes instruments
  • Analysis and interpretation of patient-centered outcomes data
  • See links below to our online education webinars related to these research topics 

Current I-SIG Initiatives:

Watch here for announcements of current I-SIG initiatives.

Annual Conference Activities:

2016 Annual Symposium:

Topic to be determined

Past Symposium Topics:

2015:  Bring Your Own Device (BYOD): trends, best practices, challenges….where do PRO measures go from here?

2014:  Advancing Measurement Science Beyond PROs: Patient-Centeredness and Validity Across All Clinical Outcome Assessments

2013:  Innovations for Patient Engagement in Health Outcomes Development, Selection and Measurement: Opportunities and Limitations

2012:  Perspectives on Mixed Methods to Assess Content Validity of a Patient Reported Outcome

2011:  To Qualify or Not to Qualify: Benefits and Challenges of PRO Instrument Qualification from Industry, Academic, and Regulatory Perspectives

Communication and Information Sharing

We encourage active communication between members.

  • Connect with other I-SIG researchers using the ISOQOL Membership Directory.
    • You can join the I-SIG by logging into your member profile and selecting Industry SIG.
  • Review the Quality of Life Quarterly, ISOQOL's quarterly newsletter, to keep up to date.
  • Consider the I-SIG Teamwork and ISOQOL LinkedIn as a way to connect with fellow I-SIG members.
  • Contact one of the chairs for more information.

Online Education

Watch here for announcements of upcoming webinars.

Archived webinars: 

Applying the FDA Patient-reported Outcome (PRO) Guidance to Performance Outcome (PerfO) Measures

Group Concept Mapping: A patient-centric, mixed-methods, approach to understand the patients' experiences and support outcomes strategy

Interpretation of PRO Data within Clinical Trials (not available via website)

Leadership

Current Chair: Josephine Norquist

Current Co-Chair: Emuella Flood

 

Josephine Norquist

Josephine Norquist is the Patient-Reported Outcome (PRO) & Study Endpoint Group Lead at Merck Sharp & Dohme, Corp. In her role Josephine leads, develops and implements endpoint strategies for global clinical trials across several therapeutic areas. She leads endpoint strategies and interactions with agencies on Clinical Outcome Assessments (COAs) to be used to support labeling claims and/or HTA/reimbursement. She is one of the Merck’s representatives on the C-PATH PRO Consortium, chairs the ISOQOL Industry SIG (previously known as IAC) and is part of the Study Endpoints Special Interest Group within DIA. Before joining Merck, she worked at the University of Oxford, Institute of Health Sciences, Department of Public Health in Oxford, U.K., where she was a Research Officer responsible for statistical analyses, report writing, and manuscript preparation in the areas of patient-reported outcomes. Prior to that, she was a Research Statistician at the Center on Outcomes, Research and Education (CORE) at Evanston Northwestern Healthcare in Evanston, IL. She earned her B.S. in Statistics and Economics from the Universita’ degli Studi di Palermo (Italy) and her M.S. in Statistics from Northwestern University (IL). Since completing her graduate degree, Josephine’s primary focus has been in the development and validation of PRO/COA measures, to support both regulatory and reimbursement requirements.  She has written many peer-reviewed journal articles and research report summaries on PRO measures and has created several endpoint dossiers for submissions to regulatory agencies.

Emuella Flood

Emuella Flood is a Senior Principal within ICON Clinical Outcomes Assessments (COA) and leads the US East Coast COA team in Gaithersburg, Maryland.  She began her career in COA research nearly 20 years ago at MEDTAP International / UBC (now Evidera) before joining Oxford Outcomes in 2006 and ICON in 2011 through acquisition. Emuella has directed the development of COAs, patient preference/conjoint and satisfaction surveys, and patient and caregiver-reported burden of illness surveys for both adult and pediatric populations and across numerous therapeutic areas. She has extensive experience in qualitative research and has presented on best practices at COA professional conferences.  In addition to co-chairing the I-SIG, Emuella leads the DIA Study Endpoints Community Educational Series Committee, is a member of the Patient Preference Methodology Working Group of the Medical Device Innovation Consortium (MDIC), and is on the editorial board of The Patient. She has contributed to over 80 peer-reviewed papers and abstracts.

INTERNATIONAL SOCIETY FOR QUALITY OF LIFE RESEARCH
555 East Wells Street, Suite 1100, Milwaukee, WI USA 53202
Phone: +1 (414) 918-9797; Fax: +1 (414) 276-3349
Email: info@isoqol.org

Facebook Twitter LinkedIn

DISCLAIMER
Throughout the website, ISOQOL provides outside resources that may provide assistance to people interested in health-related quality of life and its assessment. It is recommended that readers conduct their own evaluation of the information outside of ISOQOL activities.

TERMS OF USE  |  PRIVACY POLICY

Home  |  About ISOQOL  |  Membership  |  Research & Publications  |  Education & Events  |  Special Interest Groups  |  Job Board  |  Site Map
© Copyright 2017 International Society for Quality of Life Research. All rights Reserved.